Renal imaging with ultrasound contrast: Current status

Radiologic Clinics of North America

Volumn 41, Issue 5, 2003, Pages 963-978

  Robbin, Michelle L ^a   Lockhart, Mark E ^a   Barr, Richard G ^b  

^a University of Alabama at Birmingham   (United States)

^b ST ELIZABETH HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECHO CONTRAST MEDIUM; FS 069; PERFLUOROOCTYL BROMIDE; PERFLUTREN; SHU 508; SONOVUE;

CATHETER ABLATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOGRAPHY; FOLLOW UP; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY CYST; KIDNEY PERFUSION; KIDNEY TOMOGRAPHY; KIDNEY TUMOR; NEPHROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PYELONEPHRITIS; RENOGRAPHY; REVIEW;

EID: 0141518528     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-8389(03)00070-8     Document Type: Review

References (69)

1. Robbin ML. Ultrasound contrast agents: a promising future. Radiol Clin North Am 2001;39:399-414.
2. Correas JM, Hélénon O, Moreau JF. Contrast-enhanced ultrasonography of native and transplanted kidney diseases. Eur Radiol 1999;9(suppl 3):S394-400.
3. Gramiak R, Shah PM. Echocardiography of the aortic root. Invest Radiol 1968;3:356-66.
4. Robbin ML, Eisenfeld AM. Perflenapent emulsion: a US contrast agent for diagnostic radiology - multicenter, double-blind comparison with a placebo. Radiology 1998;207:717-22.
5. Lopez-Ben R, Robbin ML, Weber TM, Smith JK, Needleman L, Berland LL. Doppler sonographic enhancement of hepatic hemangiomas and hepatocellular carcinomas after perflenapent emulsion: preliminary study. J Ultrasound Med 1999;18:109-16.
6. Robbin ML. The promise of sonographic contrast agents in the kidney. In: Nanda NC, Schlief R, Goldberg BB, editors. Advances in echo imaging using contrast enhancement. 2nd edition. The Netherlands: Kluwer Academic Publishers; 1997. p. 525-41.
7. Melany ML, Grant EG, Duerinckx AJ, Watts TM, Levine BS. Ability of a phase shift US contrast agent to improve imaging of the main renal arteries. Radiology 1997;205:147-52.
8. Lencioni R, Cioni D, Bartolozzi C. Tissue harmonic and contrast-specific imaging: back to gray scale in ultrasound. Eur Radiol 2002;12:151-65.
9. Burns PN. Harmonic imaging with ultrasound contrast agents. Clin Radiol 1996;51(suppl 1):50-5.
10. Goldberg BB, Liu JB, Forsberg F. Ultrasound contrast agents: a review. Ultrasound Med Biol 1994;20: 319-33.
11. Greenlee RT, Murray T, Bolden S, Wingo PH. Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33.
12. Hellsten S, Johnsen J, Berge T, Linell F. Clinically unrecognized renal cell carcinoma. Eur Urol 1990; 18(suppl 2):2-3.
13. Guinan PD, Vogelzang NJ, Fremgen AM, Chmiel JS, Sylvester JL, Sener SF, et al. Renal cell carcinoma: tumor size, stage and survival. J Urol 1995;153:901-3.
14. McNichols DW, Segura JW, DeWeerd JH. Renal cell carcinoma: long-term survival and late recurrence. J Urol 1981;126:17-23.
15. Dinney CPN, Awad SA, Gajewski JB, Belitsky P, Lannon SG, Mack FG, et al. Analysis of imaging modalities, staging systems, and prognostic indicators for renal cell carcinoma. Urology 1992;39:122-9.
16. Tsui KH, Shvarts O, Smith RB, Figlin RA, DeKernion JB, Belldegrun A. Prognostic Indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol 2000;163:1090-5.
17. Scher HI, Motzer RJ. Bladder and renal cell carcinoma. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo D, Jameson JL, editors. Harrison's principles of internal medicine. New York: McGraw-Hill; 1999. p. 604-7.
18. Davidson AJ, Hayes WS, Hartman DS, McCarthy WF, Davis Jr CJ. Renal oncocytoma and carcinoma: failure of differentiation with CT. Radiology 1993;186: 693-6.
19. Reichelt O, Wunderlich H, Weirich T, Schlichter A, Schubert J. Computerized contrast angiosonography: a new diagnostic tool for the urologist. BJU Int 2001; 88:9-14.
20. Atkins MB, Garnick MB. Renal neoplasia. In: Brenner BM, editor. Brenner and Rector's the kidney. 6th edition. Philadelphia: WB Saunders; 2000. p. 1044-68.
21. Bosniak MA. The small (≤ 3.0 cm) renal parenchymal tumor: detection, diagnosis, and controversies. Radiology 1991;179:307-17.
22. Jamis-Dow CA, Choyke PL, Jennings SB, Linehan WM, Thakore KN, Walther MM. Small (≤ 3cm) renal masses: detection with CT versus US and pathologic correlation. Radiology 1996;198:785-8.
23. Forman HP, Middleton WD, Melson GL, McDlennan BL. Hyperechoic renal cell carcinomas: increase in detection at US. Radiology 1993;188:431-4.
24. Yamashita Y, Ueno S, Makita O, Ogata I, Hatanaka Y, Watanabe O, et al. Hyperechoic renal tumors: anechoic rim and intratumoral cysts in US differentiation of renal cell carcinoma from angiomyolipoma. Radiology 1993;188:179-82.
25. Siegel CL, Middleton WD, Teefey SA, McClennan BL. Angiomyolipoma and renal cell carcinoma: US differentiation. Radiology 1996;198:789-93.
26. Hélénon O, Merran S, Paraf F, Melki P, Correas JM, Chrétien Y, et al. Unusual fat-containing tumors of the kidney: a diagnostic dilemma. Radiographics 1997;17: 129-44.
27. Ascenti G, Zimbaro G, Mazziotti S, Gaeta M, Settineri N, Scribano E. Usefulness of power Doppler and contrast-enhanced sonography in the differentiation of hyperechoic renal masses. Abdom Imaging 2001;26: 654-60.
28. Bosniak MA. Difficulties in classifying cystic lesions of the kidney. Urol Radiol 1991;13:91-3.
29. Kim AY, Kim SH, Kim YJ, Lee IH. Contrast-enhanced power Doppler sonography for differentiation of cystic renal lesions: preliminary study. J Ultrasound Med 1999;18:581-8.
30. Bosniak MA. The use of the Bosniak classification system for renal cysts and cystic tumors. J Urol 1997; 157:1852-3.
31. Yeh HC. Some misconceptions and pitfalls in ultrasonography. Ultrasound Quarterly 2001;17:129-55.
32. Ascenti G, Zimbaro G, Mazziotti S, Gaeta M, Lamberto S, Scribano E. Contrast-enhanced power Doppler US in the diagnosis of renal pseudotumors. Eur Radiol 2001;11:2496-9.
33. Abdulla C, Kalra MK, Saini S, Maher MM, Ahmad E, Halpern E, et al. Pseudoenhancement of simulated renal cysts in a phantom using different multidetector CT scanners. AJR Am J Roentgenol 2002; 179:1473-6.
34. Barr RG, Robbin ML, Peterson C. Definity-enhanced ultrasound imaging of the kidney in patients with indeterminate masses: value of contrast harmonic imaging with bolus and infusion administration. Chicago: Radiological Society of North America; 2001.
35. Fommei E, Volterrani D. Renal nuclear medicine. Semin Nucl Med 1995;25:183-94.
36. Nally Jr JV. Provocative captopril testing in the diagnosis of renovascular hypertension. Urol Clin North Am 1994;21:227-34.
37. Bourgoignie JJ, Rubbert K, Sfakianakis GN. Angiotensin-converting enzyme-inhibited renography for the diagnosis of ischemic kidneys. Am J Kidney Dis 1994;24:665-73.
38. Prokop M. Protocols and future directions in imaging of renal artery stenosis: CT angiography. J Comput Assist Tomogr 1999;23(suppl 1):S101-10.
39. Wittenberg G, Kenn W, Tschammler A, Sandstede J, Hahn D. Spiral CT angiography of renal arteries: comparison with angiography. Eur Radiol 1999;9:546-51.
40. Tello R, Thomson KR, Witte D, Becker GJ, Tress BM. Standard dose Gd-DTPA dynamic MR of renal arteries. J Magn Reson Imaging 1998;8:421-6.
41. Lufft V, Lufft LH, Fels LM, Egbeyong-Baiyee D, Tusch G, Galanski M, et al. Contrast media nephropathy: intravenous CT angiography versus intraarterial digital subtraction angiography in renal artery stenosis: a prospective randomized trial. Am J Kidney Dis 2002;40:236-42.
42. Cochran ST, Krasny RM, Danovitch GM, Rajfer J, Barbaric ZM, Wilkinson A, et al. Helical CT angiography for examination of living renal donors. AJR Am J Roentgenol 1997;168:1569-73.
43. Bude RO, Forauer AR, Caoili EM, Nghiem HV. Is it necessary to study accessory arteries when screening the renal arteries for renovascular hypertension. Radiology 2003;226:411-6.
44. Stavros AT, Parker SH, Yakes WF, Chantelois AE, Burke BJ, Meyers PR, et al. Segmental stenosis of the renal artery: pattern recognition of tardus and parvus abnormalities with duplex sonography. Radiology 1992;184:487-92.
45. House MK, Dowling RJ, King P, Bourke JL, Jardine C, Thomson KR, et al. Doppler ultrasound (pre- and post-contrast enhancement) for detection of recurrent stenosis in stented renal arteries: preliminary results. Australas Radiol 2000;44:36-40.
46. Lencioni R, Pinto S, Cioni D, Bartolozzi C. Contrast-enhanced Doppler ultrasound of renal artery stenosis: prologue to a promising future. Echocardiography 1999; 16(part 2):767-73.
47. Hélénon O, Rody F, Correas JM, Melki P, Chauveau D, Chretien Y, et al. Color Doppler US of renovascular disease in native kidneys. Radiographics 1995;15: 833-54.
48. Taylor GA, Barnewolt CE, Claudon M, Dunning PS. Depiction of renal perfusion defects with contrast-enhanced harmonic sonography in a porcine model. AJR Am J Roentgenol 1999;173:757-60.
49. Girard MS, Mattrey RF, Baker KG, Peterson T, Deiranieh LH, Steinbach GC. Comparison of standard and second harmonic B-mode sonography in the detection of segmental renal infarction with sonographic contrast in a rabbit model. J Ultrasound Med 2000;19:185-92.
50. Yücel C, Özdemir H, Akpek S, Gürel K, Kapucu O, Araç M. Renal infarct: contrast-enhanced power Doppler sonographic findings. J Clin Ultrasound 2001; 29:237-42.
51. Dacher JN, Pfister C, Monroc M. Power Doppler sonographic pattern of acute pyelonephritis in children: comparison with CT. AJR Am J Roentgenol 1996; 166:1451-5.
52. Winters WD. Power Doppler sonographic evaluation of acute pyelonephritis in children. J Ultrasound Med 1996;15:91-6.
53. Clautice-Engle T, Jeffrey Jr RB. Renal hypoperfusion: value of power Doppler imaging. AJR Am J Roentgenol 1997;168:1227-31.
54. Farhat W, Traubici J, Sherman C, Williams T, Babyn P, McLorie G. Reliability of contrast enhanced sonography with harmonic imaging for detecting early renal scarring in experimental pyelonephritis in a porcine model: preliminary results. J Urol 2002;168:1114-7.
55. Kim B, Lim HK, Choi MH, Woo JY, Ryu J, Kim S, et al. Detection of parenchymal abnormalities in acute pyelonephritis by pulse inversion harmonic imaging with or without microbubble ultrasonographic contrast agent: correlation with computed tomography. J Ultrasound Med 2001;20:5-14.
56. Aronson S, Wiencek JB, Feinstein SB. Assessment of renal blood flow with contrast ultrasonography. Anesth Analg 1993;76:964-70.
57. Rubin JM, Fowlkes JB, Tuthill TA, Moskalik AP, Rhee RT, Adler RS, et al. Speckle decorrelation flow measurement with B-mode US of contrast agent flow in a phantom and in rabbit kidney. Radiology 1999;213: 429-37.
58. Verbeek XA, Willigers JM, Prinzen FW, Peschar M, Ledoux LA, Hoeks AP. High-resolution functional imaging with ultrasound contrast agents based on RF processing in an in vivo kidney experiment. Ultrasound Med Biol 2001;27:223-33.
59. Arger PH, Sehgal CM, Pugh CR, Kirchoffer JI, Kotlar EY. Evaluation of change in blood flow by contrast-enhanced power Doppler imaging during norepinephrine-induced renal vasoconstriction. J Ultrasound Med 1999;18:843-51.
60. Claudon M, Barnewolt CE, Taylor GA, Dunning PS, Gobet R, Badawy AB. Renal blood flow in pigs: changes depicted with contrast-enhanced harmonic US imaging during acute urinary obstruction. Radiology 1999;212:725-31.
61. Wei K, Le E, Bin JP, Coggins M, Thorpe J, Kaul S. Quantification of renal blood flow with contrast-enhanced ultrasound. J Am Coll Cardiol 2001;37: 1135-40.
62. Hosotani Y, Takahashi N, Kiyomoto H, Ohmori K, Hitomi H, Fujioka H, et al. A new method for evaluation of split renal cortical blood flow with contrast echography. Hypertens Res 2002;25:77-83.
63. Schlosser T, Pohl C, Veltmann C, Lohmaier S, Goenechea J, Ehlgen A, et al. Feasibility of the flash-replenishment concept in renal tissue: which parameters affect the assessment of the contrast replenishment. Ultrasound Med Biol 2001;27:937-44.
64. McGahan JP, Richards JR, Jones D, Gersovich EO. Use of ultrasonography in the patient with acute renal trauma. J Ultrasound Med 1999;18:207-13.
65. Schmiedl UP, Carter S, Martin RW, Eubank W, Winter T, Chang PP, et al. Sonographic detection of acute parenchymal injury in an experimental porcine model of renal hemorrhage: gray-scale imaging using a sonographic contrast agent. AJR Am J Roentgenol 1999; 173:1289-94.
66. Hochmuth A, Fleck M, Hauff P, Reinhardt M, Kosmehl H, Hilger I, et al. First experiences in using a new ultrasound mode and ultrasound contrast agent in the diagnosis of blunt renal trauma: a feasibility study in an animal model. Invest Radiol 2000;35:205-11.
67. Liu JB, Merton DA, Goldberg BB, Rawool NM, Shi WT, Forsberg F. Contrast-enhanced two and three dimensional sonography for evaluation of intra-abdominal hemorrhage. J Ultrasound Med 2002;21:161-9.
68. Ogan K, Jacomides L, Dolmatch BL, Rivera FJ, Dellaria MF, Josephs SC, et al. Percutaneous radiofrequency ablation of renal tumors: technique, limitations, and morbidity. Urology 2002;60:954-8.
69. Solbiati L, Goldberg SN, Ierace T, Dellanoce M, Livraghi T, Gazelle GS. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent: early experience. Radiology 1999;211:643-9.